This is non-interventional study of voriconazole IV formulation in clinical use, which was
mandated by the Korean government agency following the approval of Vfend in the Republic of
- Invasive aspergillosis and other serious fungal infections.
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: